Cancer Care Ontario | Cancer Care Ontario

363 Results

Guidelines and Advice

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Status: Current

Mar 2019

Guidelines and Advice

Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group

Status: Current
Version: 1

Aug 2019

Guidelines and Advice

Oncology Nursing Telepractice Standards

Status: Current
Version: N/A

Aug 2019

Guidelines and Advice

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Status: Current
ID: GL 3-20
Version: N/A

Aug 2019

Guidelines and Advice

Management of Cancer Medication-Related Infusion Reactions

Status: Current
Version: 1

Aug 2019

Guidelines and Advice

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Guidelines and Advice

Systemic therapy of denosumab in altering surgical outcomes in patients with giant cell tumour of bone

Status: Current
ID: ES 11-13

Feb 2021

Guidelines and Advice

Virtual Care in Patients with Cancer: A Systematic Review

Status: Current
ID: ES 30-1

Mar 2021

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group

Oncology Nursing Telepractice Standards

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Management of Cancer Medication-Related Infusion Reactions

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Systemic therapy of denosumab in altering surgical outcomes in patients with giant cell tumour of bone

Virtual Care in Patients with Cancer: A Systematic Review

Pages